Share on StockTwits

Illumina (NASDAQ:ILMN) saw a significant drop in short interest in April. As of April 30th, there was short interest totalling 20,100,661 shares, a drop of 7.0% from the April 15th total of 21,617,776 shares, Analyst Ratings News reports. Approximately 15.9% of the company’s stock are short sold. Based on an average daily volume of 2,712,517 shares, the days-to-cover ratio is currently 7.4 days.

In other Illumina news, Director Roy A. Whitfield unloaded 4,000 shares of Illumina stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $143.71, for a total value of $574,840.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

A number of research firms have recently commented on ILMN. Analysts at Ned Davis Research upgraded shares of Illumina from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Separately, analysts at Maxim Group upgraded shares of Illumina from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. They now have a $205.00 price target on the stock. Finally, analysts at Bank of America reiterated a “buy” rating on shares of Illumina in a research note on Wednesday, April 23rd. They now have a $195.00 price target on the stock. Eight research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $144.34.

Illumina (NASDAQ:ILMN) opened at 144.02 on Monday. Illumina has a 52 week low of $66.11 and a 52 week high of $183.30. The stock has a 50-day moving average of $142.2 and a 200-day moving average of $132.3. The company has a market cap of $18.492 billion and a price-to-earnings ratio of 101.79.

Illumina (NASDAQ:ILMN) last posted its quarterly earnings results on Tuesday, April 22nd. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.01. The company had revenue of $421.00 million for the quarter, compared to the consensus estimate of $391.50 million. During the same quarter in the previous year, the company posted $0.46 earnings per share. The company’s revenue for the quarter was up 27.2% on a year-over-year basis. On average, analysts predict that Illumina will post $2.16 earnings per share for the current fiscal year.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.